Arrow (ARW) Q4 2024 Earnings Call Transcript

Arrow Electronics reported Q4 sales of $7.3 billion and non-GAAP EPS of $2.97, both above guidance, despite revenue still falling 7% year over year. Enterprise Computing Solutions was a standout, with sales up 12% and billings up 10%, while consolidated gross margin held at 11.7% and operating cash flow remained positive for a sixth straight quarter. Management guided Q1 sales to $5.98 billion-$6.58 billion and EPS of $1.30-$1.50, citing a 200 bps FX headwind and continued weakness in components, but said inventory correction appears late-cycle and demand in AI, hybrid cloud and cybersecurity is improving.

Analysis

ARW looks less like a clean cyclical inflection and more like a balance-sheet repair story with operating leverage attached. The important read-through is that inventory normalization and normalized turns are now supporting cash conversion before they fully support revenue, which means the equity can re-rate on quality of earnings even if top-line recovery remains uneven for another 1-2 quarters. That matters because distributors usually bottom in multiples before they bottom in sales; the market tends to price the first derivative of working capital improvement, not the absolute level of demand.

The second-order winner is the enterprise IT/cloud/security ecosystem, where ArrowSphere and recurring software attach can offset weaker semiconductor cyclicality. If ECS keeps comping flat to up while components remain soft, the mix shift should gradually lift consolidated margin quality and reduce the market’s willingness to value ARW purely as a “semi proxy.” The risk is that the cyclical bottom proves longer than management implies: if Europe stays sub-seasonal and FX persists, the near-term earnings step-down can overwhelm the inventory narrative and keep the stock trapped in a low-multiple range.

For the supplier base, the message is subtle but important: the channel is no longer de-stocking aggressively, yet it is also not restocking. That limbo typically delays a broad semiconductor upcycle because OEMs wait for clearer visibility before rebuilding buffers. The contrarian angle is that consensus may be underestimating how much earnings power is already embedded in normalized turns and cost-out; if volume merely stabilizes, the combination of expense reduction and lower working capital can generate outsized FCF without a dramatic revenue recovery.

Key Decisions for Investors

• Go long ARW on weakness over the next 1-4 weeks: favor a starter position now, add only if the stock holds after guidance-driven digestion. Base case is a rerating toward a mid-cycle distributor multiple as FCF and inventory turn data keep improving; risk is another quarter of muted components demand and FX drag.
• Buy ARW Jan-2026 call spreads rather than outright stock if you want cyclical upside with defined risk. The setup is attractive because the market can reward margin/working-capital improvement before revenue inflects, but upside is capped if the macro recovery stalls.
• Pair trade: long ARW / short a higher-beta semiconductor distributor or components proxy over 3-6 months. The edge is that ARW now has a cleaner cash-conversion story and a diversified ECS cushion, while pure cyclicals remain more exposed to a delayed restock.
• If already long, hedge with a short-dated put spread into the next 30-45 days. The key short-term risk is that Q1 EPS de-rates on seasonality and FX even if the medium-term setup improves.
• Monitor for an add-on signal only if book-to-bill moves clearly above parity and backlog starts re-accelerating. That is the point where the market will likely price a broader semiconductor upcycle, turning ARW from a balance-sheet story into an earnings-upcycle story.